Groucho Binds Two Conserved Regions of LEF-1 for HDAC-dependent Repression

Overview

Journal BMC Cancer

Publisher Biomed Central

Specialty Oncology

Date 2009 May 23

PMID 19460168

Citations 63

Authors

Laura Arce

Kira T Pate

Marian L Waterman

Affiliations

Soon will be listed here.

Abstract

Background: Drosophila Groucho and its human Transducin-like-Enhancer of Split orthologs (TLEs) function as transcription co-repressors within the context of Wnt signaling, a pathway with strong links to cancer. The current model for how Groucho/TLE's modify Wnt signaling is by direct competition with beta-catenin for LEF/TCF binding. The molecular events involved in this competitive interaction are not defined and the actions of Groucho/TLEs within the context of Wnt-linked cancer are unknown.

Methods: We used in vitro protein interaction assays with the LEF/TCF family member LEF-1, and in vivo assays with Wnt reporter plasmids to define Groucho/TLE interaction and repressor function.

Results: Mapping studies reveal that Groucho/TLE binds two regions in LEF-1. The primary site of recognition is a 20 amino acid region in the Context Dependent Regulatory domain. An auxiliary site is in the High Mobility Group DNA binding domain. Mutation of an eight amino acid sequence within the primary region (RFSHHMIP) results in a loss of Groucho action in a transient reporter assay. Drosophila Groucho, human TLE-1, and a truncated human TLE isoform Amino-enhancer-of-split (AES), work equivalently to repress LEF-1*beta-catenin transcription in transient reporter assays, and these actions are sensitive to the HDAC inhibitor Trichostatin A. A survey of Groucho/TLE action in a panel of six colon cancer cell lines with elevated beta-catenin shows that Groucho is not able to repress transcription in a subset of these cell lines.

Conclusion: Our data shows that Groucho/TLE repression requires two sites of interaction in LEF-1 and that a central, conserved amino acid sequence within the primary region (F S/T/P/xx y I/L/V) is critical. Our data also reveals that AES opposes LEF-1 transcription activation and that both Groucho and AES repression require histone deacetylase activity suggesting multiple steps in Groucho competition with beta-catenin. The variable ability of Groucho/TLE to oppose Wnt signaling in colon cancer cells suggests there may be defects in one or more of these steps.

Citing Articles

Sall4 regulates posterior trunk mesoderm development by promoting mesodermal gene expression and repressing neural genes in the mesoderm.

Pappas M, Kawakami H, Corcoran D, Chen K, Scott E, Wong J Development. 2024; 151(5).

PMID: 38345319 PMC: 10946440. DOI: 10.1242/dev.202649.

A distinct isoform of lymphoid enhancer binding factor 1 (LEF1) epigenetically restricts EBV reactivation to maintain viral latency.

Ward B, Prasai K, Schaal D, Wang J, Scott R PLoS Pathog. 2023; 19(12):e1011873.

PMID: 38113273 PMC: 10763950. DOI: 10.1371/journal.ppat.1011873.

Genetic Disruption of Cilia-Associated Signaling Pathways in Patients with VACTERL Association.

Ritter J, Lisec K, Klinner M, Heinrich M, von Schweinitz D, Kappler R Children (Basel). 2023; 10(5).

PMID: 37238430 PMC: 10217539. DOI: 10.3390/children10050882.

WNT3a Signaling Inhibits Aromatase Expression in Breast Adipose Fibroblasts-A Possible Mechanism Supporting the Loss of Estrogen Responsiveness of Triple-Negative Breast Cancers.

Kaiser A, Eiselt G, Bechler J, Huber O, Schmidt M Int J Mol Sci. 2023; 24(5).

PMID: 36902090 PMC: 10003471. DOI: 10.3390/ijms24054654.

Different types of reactions to E7386 among colorectal cancer patient-derived organoids and corresponding CAFs.

Imai T, Naruse M, Ochiai M, Matsumoto K, Ikeda S, Kani M Oncol Lett. 2022; 24(1):221.

PMID: 35707761 PMC: 9178669. DOI: 10.3892/ol.2022.13342.

References

Stifani S, Blaumueller C, Redhead N, Hill R, Artavanis-Tsakonas S . Human homologs of a Drosophila Enhancer of split gene product define a novel family of nuclear proteins. Nat Genet. 1992; 2(4):343. DOI: 10.1038/ng1292-343a. View

Ilyas M, Novelli M, Wilkinson K, Tomlinson I, Abbasi A, Forbes A . Tumour recurrence is associated with Jass grouping but not with differences in E-cadherin expression in moderately differentiated Dukes' B colorectal cancers. J Clin Pathol. 1997; 50(3):218-22. PMC: 499816. DOI: 10.1136/jcp.50.3.218. View

Rowan A, Lamlum H, Ilyas M, Wheeler J, Straub J, Papadopoulou A . APC mutations in sporadic colorectal tumors: A mutational "hotspot" and interdependence of the "two hits". Proc Natl Acad Sci U S A. 2000; 97(7):3352-7. PMC: 16243. DOI: 10.1073/pnas.97.7.3352. View

Levanon D, Goldstein R, Bernstein Y, Tang H, Goldenberg D, Stifani S . Transcriptional repression by AML1 and LEF-1 is mediated by the TLE/Groucho corepressors. Proc Natl Acad Sci U S A. 1998; 95(20):11590-5. PMC: 21685. DOI: 10.1073/pnas.95.20.11590. View

Courey A, Jia S . Transcriptional repression: the long and the short of it. Genes Dev. 2001; 15(21):2786-96. DOI: 10.1101/gad.939601. View

Sierra J, Yoshida T, Joazeiro C, Jones K . The APC tumor suppressor counteracts beta-catenin activation and H3K4 methylation at Wnt target genes. Genes Dev. 2006; 20(5):586-600. PMC: 1410807. DOI: 10.1101/gad.1385806. View

Cavallo R, Cox R, Moline M, Roose J, Polevoy G, Clevers H . Drosophila Tcf and Groucho interact to repress Wingless signalling activity. Nature. 1998; 395(6702):604-8. DOI: 10.1038/26982. View

Daniels D, Weis W . Beta-catenin directly displaces Groucho/TLE repressors from Tcf/Lef in Wnt-mediated transcription activation. Nat Struct Mol Biol. 2005; 12(4):364-71. DOI: 10.1038/nsmb912. View

Faux M, Ross J, Meeker C, Johns T, Ji H, Simpson R . Restoration of full-length adenomatous polyposis coli (APC) protein in a colon cancer cell line enhances cell adhesion. J Cell Sci. 2003; 117(Pt 3):427-39. DOI: 10.1242/jcs.00862. View

10.

Sekiya T, Zaret K . Repression by Groucho/TLE/Grg proteins: genomic site recruitment generates compacted chromatin in vitro and impairs activator binding in vivo. Mol Cell. 2007; 28(2):291-303. PMC: 2083644. DOI: 10.1016/j.molcel.2007.10.002. View

11.

Heinen C, Richardson D, White R, Groden J . Microsatellite instability in colorectal adenocarcinoma cell lines that have full-length adenomatous polyposis coli protein. Cancer Res. 1995; 55(21):4797-9. View

12.

Miyaki M, Konishi M, Enomoto M, Igari T, Tanaka K, Muraoka M . Characteristics of somatic mutation of the adenomatous polyposis coli gene in colorectal tumors. Cancer Res. 1994; 54(11):3011-20. View

13.

Wang Z, Vogelstein B, Kinzler K . Phosphorylation of beta-catenin at S33, S37, or T41 can occur in the absence of phosphorylation at T45 in colon cancer cells. Cancer Res. 2003; 63(17):5234-5. View

14.

Roose J, Clevers H . TCF transcription factors: molecular switches in carcinogenesis. Biochim Biophys Acta. 1999; 1424(2-3):M23-37. DOI: 10.1016/s0304-419x(99)00026-8. View

15.

Carlsson P, Waterman M, Jones K . The hLEF/TCF-1 alpha HMG protein contains a context-dependent transcriptional activation domain that induces the TCR alpha enhancer in T cells. Genes Dev. 1993; 7(12A):2418-30. DOI: 10.1101/gad.7.12a.2418. View

16.

Westendorf J . Transcriptional co-repressors of Runx2. J Cell Biochem. 2006; 98(1):54-64. DOI: 10.1002/jcb.20805. View

17.

Hovanes K, Li T, Munguia J, Truong T, Milovanovic T, Marsh J . Beta-catenin-sensitive isoforms of lymphoid enhancer factor-1 are selectively expressed in colon cancer. Nat Genet. 2001; 28(1):53-7. DOI: 10.1038/ng0501-53. View

18.

Jimenez G, Verrijzer C, Ish-Horowicz D . A conserved motif in goosecoid mediates groucho-dependent repression in Drosophila embryos. Mol Cell Biol. 1999; 19(3):2080-7. PMC: 84001. DOI: 10.1128/MCB.19.3.2080. View

19.

van de Wetering M, Sancho E, Verweij C, de Lau W, Oving I, Hurlstone A . The beta-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells. Cell. 2002; 111(2):241-50. DOI: 10.1016/s0092-8674(02)01014-0. View

20.

Brantjes H, Roose J, van de Wetering M, Clevers H . All Tcf HMG box transcription factors interact with Groucho-related co-repressors. Nucleic Acids Res. 2001; 29(7):1410-9. PMC: 31284. DOI: 10.1093/nar/29.7.1410. View